Literature DB >> 1491389

Growth and characterization of fibroblasts obtained from bronchoalveolar lavage of patients with scleroderma.

A Ludwicka1, M Trojanowska, E A Smith, M Baumann, C Strange, J H Korn, T Smith, E C Leroy, R M Silver.   

Abstract

We describe the detection and the growth of fibroblasts with human smooth muscle cell differentiation features from bronchoalveolar lavage (BAL) fluid of 53% of patients with scleroderma, but not from healthy controls. The binding of alpha-actin, vimentin and desmin antibodies by scleroderma lung fibroblasts exceeded that of normal adult lung fibroblasts, indicating that scleroderma lung fibroblasts express some markers of human smooth muscle cell differentiation (myofibroblasts), which may account for differences in biological behavior. A mesenchymal cell phenotype was documented by mRNA analysis, showing high expression of collagen type I and fibronectin in these cells. Fibronectin is also released in significantly higher amounts by scleroderma alveolar macrophages than by macrophages from healthy donors.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1491389

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  13 in total

1.  Dabigatran, a direct thrombin inhibitor, demonstrates antifibrotic effects on lung fibroblasts.

Authors:  Galina S Bogatkevich; Anna Ludwicka-Bradley; Richard M Silver
Journal:  Arthritis Rheum       Date:  2009-11

Review 2.  Biomarkers of scleroderma lung disease: recent progress.

Authors:  Faye N Hant; Richard M Silver
Journal:  Curr Rheumatol Rep       Date:  2011-02       Impact factor: 4.592

Review 3.  Interstitial lung disease in systemic sclerosis.

Authors:  Predrag Ostojic; Marco Matucci Cerinic; Richard Silver; Kristin Highland; Nemanja Damjanov
Journal:  Lung       Date:  2007 Jul-Aug       Impact factor: 2.584

Review 4.  Histopathology and bronchoalveolar lavage.

Authors:  R M Silver; A U Wells
Journal:  Rheumatology (Oxford)       Date:  2008-10       Impact factor: 7.580

5.  Bone marrow-derived mesenchymal stem cell attenuates skin fibrosis development in mice.

Authors:  Yan Wu; Sha Huang; Jirigala Enhe; Kui Ma; Siming Yang; Tongzhu Sun; Xiaobing Fu
Journal:  Int Wound J       Date:  2013-02-15       Impact factor: 3.315

6.  Antifibrotic action of interleukin-1 receptor antagonist in lapine monoarticular arthritis.

Authors:  J Lewthwaite; S Blake; R C Thompson; T E Hardingham; B Henderson
Journal:  Ann Rheum Dis       Date:  1995-07       Impact factor: 19.103

7.  Development of Macroporous Chitosan Scaffolds for Eyelid Tarsus Tissue Engineering.

Authors:  Michelle T Sun; Andrea J O'Connor; Imogen Milne; Dhee Biswas; Robert Casson; John Wood; Dinesh Selva
Journal:  Tissue Eng Regen Med       Date:  2019-07-26       Impact factor: 4.169

8.  The PPARγ Agonist Rosiglitazone Is Antifibrotic for Scleroderma Lung Fibroblasts: Mechanisms of Action and Differential Racial Effects.

Authors:  Galina S Bogatkevich; Kristin B Highland; Tanjina Akter; Richard M Silver
Journal:  Pulm Med       Date:  2011-11-01

9.  Functional and phenotypical comparison of myofibroblasts derived from biopsies and bronchoalveolar lavage in mild asthma and scleroderma.

Authors:  Kristoffer Larsen; Johan Malmström; Marie Wildt; Camilla Dahlqvist; Lennart Hansson; György Marko-Varga; Leif Bjermer; Agneta Scheja; Gunilla Westergren-Thorsson
Journal:  Respir Res       Date:  2006-01-23

10.  Associations between peripheral blood eosinophil counts in patients with systemic sclerosis and disease severity.

Authors:  Katsutoshi Ando; Tamao Nakashita; Norihiro Kaneko; Kazuhisa Takahashi; Shinji Motojima
Journal:  Springerplus       Date:  2016-08-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.